Subscribe to Newsletter

Gert Riethmueller

The Power List 2016

Gert Riethmueller

Professor Emeritus of Immunology, Ludwig-Maximillian University of Munich

Gert is a prolific researcher with a strong interest in autoimmune diseases and cancer. He is considered a pioneer in tumor immunology and was one of the first to introduce monoclonal antibodies and immune cells into medical practice. In 1994, he published a landmark clinical study in The Lancet on the treatment of metastatic colon carcinoma, which led to the approval of the world’s first monoclonal cancer antibody (17-1A).

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine